5 Schizophrenia Clinical Trials in Oceanside, NY (2026)

Q: How do I join a clinical trial in Oceanside?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Oceanside research site will contact you.

Recruiting Schizophrenia Studies in Oceanside

NCT07379827Recruiting

Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

The purpose of this study is to describe real-world treatment patterns, effectiveness and adverse events of adults diagnosed with schizophrenia that have initiated xanomeline and trospium chloride (Ka...

Oceanside, NY1,500 participantsBristol-Myers Squibb

View Study Details

NCT07114874Recruiting

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

This study will evaluate the long-term safety of NBI-1117568 in adults with schizophrenia....

Oceanside, NY600 participantsNeurocrine Biosciences

View Study Details

NCT07227818Recruiting

Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

The main objective of the study is to evaluate NBI-1117568 compared with placebo in delaying relapse of symptoms of schizophrenia in adults who have a stable response after open-label treatment with N...

Oceanside, NY560 participantsNeurocrine Biosciences

View Study Details

NCT06961968Recruiting

Randomized Withdrawal Study in Patients With Schizophrenia

The purpose of this research is to evaluate the efficacy of dosing iloperidone long-acting injection (LAI) compared to placebo in preventing the exacerbation of symptoms in patients with schizophrenia...

Oceanside, NY400 participantsVanda Pharmaceuticals

View Study Details

NCT06229210Recruiting

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

This is a multicenter, global, 26-week, open-label study to assess the safety and tolerability of lumateperone in pediatric patients with schizophrenia, bipolar disorder or autism spectrum disorder....

Oceanside, NY300 participantsIntra-Cellular Therapies, Inc.

View Study Details

About Schizophrenia Clinical Trials in Oceanside

Schizophrenia is a chronic brain disorder affecting approximately 2.8 million US adults, characterized by hallucinations, delusions, disorganized thinking, and cognitive difficulties. While current treatments rely primarily on first- and second-generation antipsychotics (risperidone, olanzapine, clozapine), many patients experience incomplete symptom relief or significant side effects. Clinical trials are testing novel mechanisms including muscarinic receptor agonists (like KarXT/xanomeline-trospium), trace amine-associated receptor 1 (TAAR1) agonists, glutamate modulators, and long-acting injectable formulations. Treatment-resistant schizophrenia remains a major focus area, with trials seeking patients who have not adequately responded to standard antipsychotic therapy.

There are currently 5 schizophrenia clinical trials recruiting participants in Oceanside, NY. These studies are seeking a combined 3,360 participants. Research is being sponsored by Bristol-Myers Squibb, Neurocrine Biosciences, Vanda Pharmaceuticals and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Schizophrenia Clinical Trials in Oceanside — FAQ

Are there schizophrenia clinical trials in Oceanside?

Yes, there are 5 schizophrenia clinical trials currently recruiting in Oceanside, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Oceanside?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Oceanside research site will contact you about next steps.

Are clinical trials in Oceanside free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Oceanside studies also compensate for your time and travel.

What schizophrenia treatments are being tested?

The 5 active trials in Oceanside are testing new therapies including novel drugs, biologics, and treatment approaches for schizophrenia.

Data updated July 13, 2026 from ClinicalTrials.gov